We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWRS icon
2551
Global Water Resources
GWRS
$256M
$90K ﹤0.01%
+8,543
New +$89.9K
OBK icon
2552
Origin Bancorp
OBK
$1.69B
$90K ﹤0.01%
4,069
+2,711
+200% +$55.6K
PGNY icon
2553
Progyny
PGNY
$1.99B
$90K ﹤0.01%
+3,476
New +$79.8K
SCSC icon
2554
Scansource
SCSC
$1.06B
$90K ﹤0.01%
+3,720
New +$88K
AY
2555
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$90K ﹤0.01%
+3,107
New +$78.3K
NTUS
2556
DELISTED
Natus Medical Inc
NTUS
$90K ﹤0.01%
+4,141
New +$94.8K
NP
2557
DELISTED
Neenah, Inc. Common Stock
NP
$90K ﹤0.01%
+1,832
New +$88.1K
MDP
2558
DELISTED
Meredith Corporation
MDP
$90K ﹤0.01%
6,177
+6,152
+24,608% +$89.6K
ALEX
2559
DELISTED
Alexander & Baldwin
ALEX
$89K ﹤0.01%
7,334
+1,845
+34% +$21.8K
RILY icon
2560
BRC Group Holdings
RILY
$303M
$89K ﹤0.01%
+4,095
New +$78.5K
RVMD icon
2561
Revolution Medicines
RVMD
$43.3B
$89K ﹤0.01%
+2,827
New +$88.9K
TRNS icon
2562
Transcat
TRNS
$888M
$89K ﹤0.01%
3,459
+3,383
+4,451% +$88.1K
UBER icon
2563
Uber
UBER
$155B
$89K ﹤0.01%
2,862
+2,006
+234% +$62.5K
WINA icon
2564
Winmark
WINA
$1.26B
$89K ﹤0.01%
519
+16
+3% +$2.34K
QVCGA
2565
DELISTED
QVC Group Inc Series A
QVCGA
$89K ﹤0.01%
+193
New +$75.3K
SYRS
2566
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$89K ﹤0.01%
+833
New +$74.8K
EVA
2567
DELISTED
Enviva Inc.
EVA
$89K ﹤0.01%
2,467
-2,016
-45% -$67K
AIU
2568
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$89K ﹤0.01%
181
+170
+1,545% +$90.6K
CAI
2569
DELISTED
CAI International, Inc.
CAI
$89K ﹤0.01%
+5,328
New +$88.8K
AMPH icon
2570
Amphastar Pharmaceuticals
AMPH
$858M
$88K ﹤0.01%
+3,929
New +$72K
AXTA icon
2571
Axalta
AXTA
$7.93B
$88K ﹤0.01%
3,884
-13,861
-78% -$284K
LILA icon
2572
Liberty Latin America Class A
LILA
$1.67B
$88K ﹤0.01%
+14,094
New +$92.5K
ODC icon
2573
Oil-Dri
ODC
$1.27B
$88K ﹤0.01%
+5,070
New +$87.8K
XHR
2574
Xenia Hotels & Resorts
XHR
$1.76B
$88K ﹤0.01%
+9,466
New +$88.2K
ZYXI
2575
DELISTED
Zynex
ZYXI
$88K ﹤0.01%
+3,913
New +$65.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.